At Hims, we’re committed to investing in a future that ensures access to safe—and in many cases life-changing—medicines for Americans nationwide. To do this, we’re scaling our supply chain with a new peptide facility.
This California-based facility houses peptide synthesizers and other state-of-the-art technology that will further verticalize our long-term ability to deliver personalized medications and meet the ever-growing demand for customized care.
This new peptide facility will allow us to further scale the vertically integrated components of our supply chain, meaning we’ll be better positioned to deliver uninterrupted care through provider-recommended treatments.
This facility deepens our commitment to keeping operations domestic, where high-quality treatments are delivered to our customers without interruption or compromise.
-Melissa Baird, COO of Hims & Hers